Health in 2 Point 00, Episode 151| MDLive (not?) IPOing, DTx Platform for Schizophrenia, & more – The Health Care Blog

Health in 2 Point 00

We’re forgetting about well being tech, and celebrating Chicago-oo! Simply kidding, right this moment on Health in 2 Point 00, Jess asks me about Truepill getting a 75M Sequence C after simply closing their B, Sana Advantages getting $20.8M, and Respectable getting $10M, each of that are in the house of well being advantages & insurance coverage for small enterprise have raised funding, MDLive closing a $50M spherical for their Digital Major Care (however weren’t they going public?), Owl Insights getting $15M from Ascension and Blue Ventures, and Boehringer Ingelheim & Click on Therapeutics engaged on a $500M deal collectively on a DTx platform for Schizophrenia sufferers. –Matthew Holt

Subscribe to Health in 2 Point 00’s Channel

Observe @boltyboy & @jessdamassa on Twitter

Subscribe to our channel and tweet us your questions utilizing the hashtag #healthin2point00!

Livongo’s Post Ad Banner 728*90

Sharing is caring!

Leave a Reply

Your email address will not be published. Required fields are marked *